Ad5-RGD-D24-GMCSF
AXP000068.1 · Oncolytic virus
- Platform
- adenovirus (Ad5, RGD-modified fiber, Delta-24, GM-CSF-armed)
- Originator
- University of Helsinki (Akseli Hemminki)
Names
| Name | Type | Source |
|---|---|---|
| Ad5-RGD-D24-GMCSF | preferred name, code | curator, paper |
Virus
- Role
- Oncolytic
- Family
- Adenoviridae
- Virus
- human adenovirus 5 (NCBI Taxonomy 28285)
- Strain
- Ad5 (RGD fiber)
- Replication
- conditionally replicating
- Modifications
- Delta-24; RGD-4C motif in fiber HI loop
- Transgenes
- CSF2
- Route
- intratumoral, intraperitoneal, intrapleural, intravenous
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (0)
No trial in the latest ClinicalTrials.gov snapshot names this program.
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 21630267 | Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors. | International journal of cancer | 2012 | name in title: Ad5-RGD-D24-GMCSF |
Notes
ATAP construct (2007-2012).
How to cite
Ad5-RGD-D24-GMCSF (AXP000068.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000068.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.